The FDA has approved the use of Gozellix, a PSMA-PET imaging agent, to help detect prostate cancer using gallium-68 ...
Telix Pharmaceuticals reported that the U.S. Food and Drug Administration approved its agent indicated for prostate cancer ...
Increase awareness about colorectal cancer to promote early diagnosis and treatment, reducing mortality rates worldwide.
If carers are society’s glue, it’s invisible – the opaque, translucent stuff that lives in the gaps: unheralded and unseen.
Father-of-two Joshua Giorgio jokes that now when he says he has his foot in his mouth he can mean it, after cancer left him requiring a jaw reconstruction from his leg bone.
A consortium of Austrian research groups from the University of Vienna, MedUni Vienna and Technikum Wien, together with ...
MELBOURNE, Australia and INDIANAPOLIS, IN, USA I March 21, 2025 I Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces ...
A research team has achieved a new milestone in 3D X-ray imaging technology. The scientists have captured high-resolution CT scans of the interior of a large, dense object -- a gas turbine blade -- ...
The PSMA-PET imaging agent will be used for patients who have suspected metastasis and those with suspected cancer recurrence.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback